Top

--Technology Readiness Evaluation (TRE) 07-1 Advanced Biological Agent Identification Technologies for the Joint Biological Point Detection System (JBPDS) Identifier Upgrade Effort

Active

USA-SNOTE-070725-007Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

The contract pertains to the Technology Readiness Evaluation (TRE) 07-1 focused on advanced biological agent identification technologies intended for the Joint Biological Point Detection System (JBPDS) identifier upgrade effort. Following the completion of Phase I in May 2007, select organizations were invited to participate in Phases II and III, which will involve rigorous laboratory evaluations of candidate technologies at Dugway Proving Ground, Utah, starting around October 9, 2007. These phases are designed to assess whether new identifier technologies offer performance improvements over existing systems, with Phase II focusing on overall technology evaluation and Phase III specifically testing automated identification capabilities for inactivated antigens in formulated tap water. The U.S. Army retains full discretion in selecting technologies and is not obligated to choose any participant. This announcement clarifies that it is not soliciting additional participants, only providing information regarding the continuation of TRE beyond Phase I. The TRE 07-1 project is separate from ongoing JBPDS contract actions. Testing will span up to four weeks and will be scored distinctly for each phase. All contractors who completed Phase I were encouraged to engage in the subsequent phases, with any inquiries directed to the U.S. Army Technology Readiness Evaluation Team. The effort is managed under the Department of Defense, located at Aberdeen Proving Ground, Maryland, and is identified under NAICS code 334511, related to electronic component manufacturing.

General Info

Technology Readiness Evaluation continues with Phases II and III testing biological agent identifier technologies.

Agency

Department Of Defense → W6QK Acc-Apg

NAICS

334511 - Search, Detection, Navigation, Guidance, Aeronautical, and Nautical System and Instrument Manufacturing

Place of Performance

Set-Aside

NONE

Documents

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PostedJul 25

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → W6QK Acc-Apg

ContactsNo contacts available

OfficeABERDEEN PROVING GROU, MD, 21010-5424, USA

Organization / AgencyDepartment Of Defense → W6QK Acc-Apg

Office AddressABERDEEN PROVING GROU, MD, 21010-5424, USA

ContactsNo contact information available

Full Description

Refer to the original Federal Business Opportunities announcement for this effort, which was published on March 20, 2007. Phase I of the TRE was completed in May 2007 and organizations which were invited to participate in Phases II & III of the TRE w ere notified by letter. This announcement is issued to provide additional information concerning the remaining Phases of the TRE. This announcement is not seeking additional participants for the upcoming phases, and any responses received as a result of th is notice will not be considered. As communicated in the March 20, 2007 announcement, Phase II evaluates identifier technologies for use with the Joint Biological Point Detection System (JBPDS). The tests are designed to provide data for the assessment of identifier technologies which may offer performance superior to that of the current system identifier. The U.S. Army is under no obligation to select any of the participating technologies. TRE 07-1 is a separate and distinct effort which has no connection to any of the JBPDS programs ongoing contract actions. Phases II & III will conduct laboratory evaluations of the proposed technologies, and are scheduled to occur at Dugway Proving Ground (DPG), UT beginning on or about 9 October 2007, for up to four wee ks in duration. All contractors selected in Phase I are encouraged to participate in the subsequent phases. Phase III will evaluate the technologies capability for automated identification of inactivated antigens in Formulated Tap Water. This testing will be scored separately from the Phase II portion of the TRE and will commence after Phase II testing has completed. All questions concerning the TRE should be submitted to the US Army Technology Readiness Evaluation Team, contact@example.gov. Format is plain text.